Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NYSE

Expert Ratings For Nomad Foods

Nomad Foods (NYSE:NOMD) has observed the following analyst ratings within the last quarter:

Benzinga

What 6 Analyst Ratings Have To Say About Equifax

Over the past 3 months, 6 analysts have published their opinion on Equifax (NYSE:EFX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

What Are Whales Doing With XPeng

A whale with a lot of money to spend has taken a noticeably bullish stance on XPeng. Looking at options history for XPeng (NYSE:XPEV) we detected 15 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Is What Whales Are Betting On Alibaba Group Holding

A whale with a lot of money to spend has taken a noticeably bullish stance on Alibaba Group Holding. Looking at options history for Alibaba Group Holding (NYSE:BABA) we detected 117 strange trades.

Benzinga

(LMT) - Analyzing Lockheed Martin Corporation's Short Interest

Lockheed Martin Corporation's (NYSE:LMT) short percent of float has fallen 15.08% since its last report. The company recently reported that it has 2.91 million shares sold short, which is 1.07% of all regular shares that are available for trading.

Benzinga

Looking Into Coca-cola Company's Recent Short Interest

Coca-cola Company's (NYSE:KO) short percent of float has risen 8.82% since its last report. The company recently reported that it has 31.95 million shares sold short, which is 0.74% of all regular shares that are available for trading.

Benzinga

HSBC Enters The Metaverse In Partnership With The Sandbox

HSBC Holdings plc (NYSE: HSBC), the second-largest banking and financial services provider in Europe, with assets of $3 Trillion, operations in over 70 countries and a network of over 5,100 branches, is the first multinational bank to enter the Metaverse — through a partnership with The San

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Alibaba Hunts For New SCMP Chief As It Devotes Former Chief To NFT Spinoff

Alibaba Group Holding Ltd (NYSE:BABA) owned South China Morning Post is on a CEO hunt, Bloomberg reports. The move coincided with Alibaba weighing options for media assets, including SCMP. Alibaba dedicated SCMP chief Gary Liu to running a spinoff to turn artwork into non-fungible tokens. Also Read: Alibaba Launches New NFT Marketplace: What…

Benzinga

Why KE Holdings Shares Are Soaring Today

KE Holdings Inc (NYSE: BEKE) shares are trading significantly higher Wednesday alongside several other Chinese stocks following a Chinese state media report indicating China's financial stability and development committee urged market stability measures and mentioned cooperation with U.S.

Benzinga

Why Ford, GM And Tesla Shares Are Rising Today

Shares of several companies in the auto & auto component sector, including Ford Motor Company (NYSE: F), General Motors Company (NYSE: GM) and Tesla Inc (NASDAQ:

Benzinga

Why BofA Bullish Is On Aluminum, Reinstating Buy Rating For Alcoa

Alcoa Corp (NYSE: AA) aims to become first quartile in aluminum by 2024, while the sentiment is bullish for aluminum due to capped Chinese supply, potential risks on Russia’s supply and Europe facing supply headwinds due to high energy costs, according to BofA Securities.

Benzinga

Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech

Protagonist Therapeutics (NASDAQ:PTGX) has received a $25 million milestone payment from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE:JNJ). The payment comes after the dosing of the third patient in the Phase 2b FRONTIER 1 clinical trial of PN-235 (JNJ-77242113). FRONTIER 1 is a Phase 2b dose-ranging study to evaluate the…

Benzinga

FDA Removes Clinical Hold On AIM ImmunoTech's Mid-Stage Ampligen Trial In Pancreatic Cancer

The FDA has lifted the clinical hold on AIM ImmunoTech Inc's (NYSE:AIM) investigational new drug (IND) application for a Phase 2 study of Ampligen for locally advanced pancreatic cancer (AMP-270). The AMP-270 clinical trial's primary objective compares the efficacy of Ampligen versus a no treatment control group following FOLFIRINOX for subjects with locally advanced…

Benzinga

Ampco-Pittsburgh Reports Q4 Sales Decline Of 3%, Expects Margins To Restore In Q1 2022

Ampco-Pittsburgh Corp (NYSE:AP) reported a fourth-quarter sales decline of 2.9% year-over-year to $84.5 million, missing the consensus of $84.9 million. The decrease in sales is attributable to the Air and Liquid Processing segment impacted by customer-requested deferrals and delays in receiving required components. Loss from operations was $(12.63) million for the quarter,…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Check Out What Whales Are Doing With CPNG

A whale with a lot of money to spend has taken a noticeably bullish stance on Coupang. Looking at options history for Coupang (NYSE:CPNG) we detected 12 strange trades.

Benzinga

Wells Fargo Whale Trades For March 16

Someone with a lot of money to spend has taken a bearish stance on Wells Fargo (NYSE:WFC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Read Why William Blair Is Optimistic On This Car Wash Company

William Blair analyst Ryan Sundby initiated coverage of Mister Car Wash Inc (NYSE:MCW) with an Outperform rating and no price target. Sundby notes Mister Car Wash has become a leader in the U.S. car wash market. The investor specifies that the car wash industry can grow at a mid-single-digit rate. The analyst predicts a significant…

Benzinga

$100 Invested In EPAM Sys 10 Years Ago Would Be Worth This Much

EPAM Sys (NYSE:EPAM) has outperformed the market over the past 10 years by 18.93% on an annualized basis.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Here's How Much You Would Have Made Owning CVS Health Stock In The Last 20 Years

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.61% on an annualized basis.

Benzinga

Why Are Kohl's Shares Trading Higher Today

Hudson's Bay, the owner of American luxury department store chain Saks Fifth Avenue, is planning a bid for the department store chain Kohl's Corp (NYSE:KSS), Reuters reported. Related: Kohl's Dismisses Takeover Offers: What Investors Need To Know In another development, Engine Capital LP issued a letter to the board of Kohl's, urging the sale of the…

Benzinga

Preview: Ranger Energy Services's Earnings

Ranger Energy Services (NYSE:RNGR) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Ranger Energy Services will report an earnings per share (EPS) of $-0.07.

Benzinga

Nio Reverses Course After Sell-Off: Will EV Stock Rally Ahead Of Earnings?

After an extended lean run, Nio, Inc. (NYSE: NIO) shares hit a trough Tuesday, weighed down by multiple factors. It appears the selling may have stalled, at least for now.

Benzinga

Expert Ratings For Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) has observed the following analyst ratings within the last quarter:

Benzinga

Peering Into Roblox Corporation Class A Common Stock's Recent Short Interest

Roblox Corporation Class A Common Stock's (NYSE:RBLX) short percent of float has fallen 15.28% since its last report. The company recently reported that it has 18.96 million shares sold short, which is 6.21% of all regular shares that are available for trading.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022

Upgrades

1 … 521 522 523 524

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.